CAMKK2 and melanoma: Wang et al. identified that the CAMKK2‒AMPK‒NRF2 signaling axis can negatively regulate ferroptosis, which might be a promising target to improve the efficacy of immunotherapy and ferroptosis inducer to treat melanoma (Wang et al., 2021).